Clonal hematopoiesis at the crossroads of Inflammaging and cardiovascular disease: Mechanistic insights and translational horizons

Soumiya Nadar, Taha K. Dohadwala, Nitish Kumaresan, Shabbeer I. Ahamed, Sumia Fatima · 2025

Read Clonal hematopoiesis at the crossroads of Inflammaging and cardiovascular disease: Mechanistic insights and translational horizons by Soumiya Nadar, Taha K. Dohadwala, Nitish Kumaresan, Shabbeer I. Ahamed, Sumia Fatima (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12738160.txt.

Description

Soumiya Nadar and four co-authors review clonal hematopoiesis, a condition where one blood stem cell lineage expands with age and carries a mutation. Their review came out in 2025. The condition is increasingly recognized as a risk factor for heart and vessel disease.

Mutations accumulate in blood stem cells during aging and give the lineage a growth edge. The cells it produces lean toward inflammation, releasing signals that promote plaque growth and instability in artery walls. That raises the risk of heart attack, stroke, and coronary disease, with some mutations carrying higher risk than others. Routine screening of healthy adults is not advised. The authors argue that targeted detection in high-risk people, plus trials of guided prevention, could turn this knowledge into care.

Catalog record

CREATORSoumiya Nadar, Taha K. Dohadwala, Nitish Kumaresan, Shabbeer I. Ahamed, Sumia Fatima
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE26 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12738160

Browse the full library · About the Tower of Babel